Issue 10/2020
Content (28 Articles)
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma
Yifei Zheng, Mingyue Zhu, Mengsen Li
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer
Yu Zeng, Nanhong Li, Wang Liu, Mingqing Zeng, Junfen Cheng, Jian Huang
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
Ying Tian, Eri Arai, Satomi Makiuchi, Noboru Tsuda, Junko Kuramoto, Kentaro Ohara, Yoriko Takahashi, Nanako Ito, Hidenori Ojima, Nobuyoshi Hiraoka, Masahiro Gotoh, Teruhiko Yoshida, Yae Kanai
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer
Mauro Guglielmo, Patricia Di Pede, Salvatore Alfieri, Cristiana Bergamini, Francesca Platini, Carla Ida Ripamonti, Ester Orlandi, Nicola Alessandro Iacovelli, Lisa Licitra, Marta Maddalo, Paolo Bossi
Oral cancer awareness campaign in Northern Germany: first positive trends in incidence and tumour stages
Katrin Hertrampf, Ron Pritzkuleit, Eva Baumann, Jörg Wiltfang, Hans-Jürgen Wenz, Annika Waldmann
Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity
Jaewang Lee, Ji Hyeon You, Daiha Shin, Jong-Lyel Roh
Hypoxia-induced downregulation of B-cell translocation gene 3 confers resistance to radiation therapy of colorectal cancer
Dening Ma, Xinyi Gao, Jinhua Tao, Hongming Yu, Zongtao Chai
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis
Li Li, Yingxing Pan, Xiaoxiang Mo, Tongtong Wei, Jinjing Song, Min Luo, Guolin Huang, Cuifang Teng, Kai Liang, Naiquan Mao, Jie Yang
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT
Giorgia Garganese, Luca Tagliaferri, Simona Maria Fragomeni, Valentina Lancellotta, Giuseppe Colloca, Giacomo Corrado, Stefano Gentileschi, Gabriella Macchia, Enrica Tamburrini, Maria Antonietta Gambacorta, Anna Fagotti, Giovanni Scambia
The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer
Arkadiusz Gzil, Izabela Zarębska, Damian Jaworski, Paulina Antosik, Justyna Durślewicz, Joanna Maciejewska, Ewa Domanowska, Natalia Skoczylas-Makowska, Navid Ahmadi, Dariusz Grzanka, Łukasz Szylberg
Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
Till Kaltofen, Valentina Preinfalk, Stephanie Schwertler, Patricia Fraungruber, Helene Heidegger, Theresa Vilsmaier, Aurelia Vattai, Bastian Czogalla, Doris Mayr, Sven Mahner, Udo Jeschke, Fabian Trillsch
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
Thomas Walter, Neil S. Hawkins, Richard F. Pollock, Fabien Colaone, Suki Shergill, Paul J. Ross
Combined microscope and endoscopy total resection of primary pineal malignant melanoma: case report and literature review
Jibo Zhang, Zhongwei Xiong, Jincao Chen
Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer
Zhenzhen Hui, Feng Wei, Hongliang Ren, Wengui Xu, Xiubao Ren
PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions
Yu Toda, Kenichi Kohashi, Yuichi Yamada, Masato Yoshimoto, Shin Ishihara, Yoshihiro Ito, Takeshi Iwasaki, Hidetaka Yamamoto, Yoshihiro Matsumoto, Yasuharu Nakashima, Masaaki Mawatari, Yoshinao Oda
Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer
Jiarong Bian, Ke Yan, Na Liu, Xingxiang Xu
Low rectal cancer treatment strategies: a cohort study assessing watch and wait
João Cortez Pinto, António Dias Pereira, Ana Pimenta, Cátia Pedro, Gonçalo Fernandez, Inês Marques, Isália Miguel, João Freire, João Maciel, José Venâncio, Luís D’Orey, Luísa Mirones, Manuel Limbert, Miguel Labareda, Paula Chaves, Ricardo Fonseca, Rita Barroca, Teresa Ferreira, Teresa Marques, Isadora Rosa
Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype
Kazuki Takada, Gouji Toyokawa, Fumihiko Kinoshita, Tomoko Jogo, Kenichi Kohashi, Sho Wakasu, Yuki Ono, Kensuke Tanaka, Taro Oba, Atsushi Osoegawa, Tetsuzo Tagawa, Koichi Azuma, Isamu Okamoto, Mototsugu Shimokawa, Yoshinao Oda, Masaki Mori
Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial
Jingde Chen, Ming Quan, Zhiqin Chen, Tianmei Zeng, Yandong Li, Ying Zhou, Yanan Hai, Yong Gao
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy
Taiki Hakozaki, Yukio Hosomi, Akihiro Shimizu, Rui Kitadai, Kie Mirokuji, Yusuke Okuma
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study
Chenwei Wang, Yadi Liao, Jiliang Qiu, Yichuan Yuan, Yuanping Zhang, Kai Li, Ruhai Zou, Yongjin Wang, Dinglan Zuo, Wei He, Yun Zheng, Binkui Li, Yunfei Yuan
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
A. Kurreck, M. Geissler, U. M. Martens, J. Riera-Knorrenschild, J. Greeve, A. Florschütz, S. Wessendorf, T. Ettrich, S. Kanzler, D. Nörenberg, M. Seidensticker, S. Held, P. Buechner-Steudel, J. Atzpodien, V. Heinemann, S. Stintzing, T. Seufferlein, A. Tannapfel, A. C. Reinacher-Schick, D. P. Modest
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib
Warit Ruanglertboon, Michael J. Sorich, Jessica M. Logan, Andrew Rowland, Ashley M. Hopkins
Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France
Anne Aarnink, Jean David Fumet, Laure Favier, Caroline Truntzer, Francois Ghiringhelli
Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis
Caroline Pahmeyer, Fabinshy Thangarajah, Dominik Ratiu, Anne Maria Schultheis, Birgid Schömig-Markiefka, Peter Mallmann, Bernd Morgenstern
Oncology services in corona times: a flash interview among German cancer patients and their physicians
Jens Büntzel, Michael Klein, Christian Keinki, Stefanie Walter, Judith Büntzel, Jutta Hübner
Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China
Hongnan Mo, Binliang Liu, Fei Ma
Correction to: Afatinib is active in osteosarcoma cell lines
Marlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, Karina Martínez-Flores, Gabriela Martínez-Nava, Javier Fernández-Torres, Alberto López-Reyes, Flavio Solca